The missing link
Molecular diagnostic tests have witnessed unprecedented advances in PCR- and next-generation sequencing technologies, and are now a mainstay that guide personalized cancer therapy.
Yet, selecting a good quality tissue sample for molecular pathology testing remains a labor-intensive, manual process, based on subjective judgements, with limitations in precision and a potential risk of error.
This critical link in the chain of precision medicine needs an overhaul to catch up with the advances made on the other ends of this process.
Xyall addresses this need with its fully automated solution, integrating the latest high-tech solutions in precision robotics, digital pathology and workflow optimization.
The Xyall Tissector solutions bridge the gap between histopathology and molecular pathology and provide a platform for innovation by computational pathology.